Cardiovascular Disease
New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
Published in Medical Letter on the CDC and FDA, November 25th, 2007
Itamar Medical's ENDO-Pat device was the diagnostic tool used in this phase of the Framingham study, which found a link between endothelial dysfunction and cardiovascular risk factors including cholesterol, blood pressure and being overweight. In light of this latest scientific confirmation of PAT technology, Itamar Medical will now promote widespread clinical use of this approach for the prevention of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cardiovascular Disease
New Research Released at AHA Confirms Itamar's PAT Technology to Diagnose Early Cardiovascular Disease - Life Sciences
New life sciences study findings reported from Albany Medical College, Medical College - Pediatrics
New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers - Anthrax
Research conducted at R. Hoile and co-researchers has updated our knowledge about anthrax - Escherichia Coli
University of Groningen reports research in Escherichia coli - West Nile Virus
Scientists at Kobe University, Medical Department target west nile virus - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
